首页> 美国卫生研究院文献>Fibrogenesis Tissue Repair >Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation
【2h】

Recent advances in renal interstitial fibrosis and tubular atrophy after kidney transplantation

机译:肾移植后肾间质纤维化和肾小管萎缩的最新进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Although kidney transplantation has been an important means for the treatment of patients with end stage of renal disease, the long-term survival rate of the renal allograft remains a challenge. The cause of late renal allograft loss, once known as chronic allograft nephropathy, has been renamed “interstitial fibrosis and tubular atrophy” (IF/TA) to reflect the histologic pattern seen on biopsy. The mechanisms leading to IF/TA in the transplanted kidney include inflammation, activation of renal fibroblasts, and deposition of extracellular matrix proteins. Identifying the mediators and factors that trigger IF/TA may be useful in early diagnosis and development of novel therapeutic strategies for improving long-term renal allograft survival and patient outcomes. In this review, we highlight the recent advances in our understanding of IF/TA from three aspects: pathogenesis, diagnosis, and treatment.
机译:尽管肾脏移植已经成为治疗肾脏疾病晚期患者的重要手段,但同种异体肾的长期存活率仍然是一个挑战。晚期同种异体肾功能衰竭的病因,曾经被称为慢性同种异体肾病,现已更名为“间质纤维化和肾小管萎缩”(IF / TA),以反映活检中观察到的组织学模式。在移植的肾脏中导致IF / TA的机制包括炎症,肾成纤维细胞的活化以及细胞外基质蛋白的沉积。识别触发IF / TA的介体和因素可能有助于早期诊断和开发新的治疗策略,以改善长期肾移植的存活率和患者预后。在这篇综述中,我们从三个方面突出了我们对IF / TA的理解的最新进展:发病机理,诊断和治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号